Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: eIF6 is potential diagnostic and prognostic biomarker that associated with 18F-FDG PET/CT features and immune signatures in esophageal carcinoma

Fig. 3

The expression of eIF6 and GLUT1 in ESCA patients with high and low 18F-FDG levels. A, B Representative PET/CT images for ESCC patients with different SUVmax values. C IHC staining for eIF6 and GLUT1 (D) in ESCC patients with high (n = 28) and low (n = 24) SUVmax values. *p < 0.05, **p < 0.01

Back to article page